Novartis Poised for Growth as CEO Hands Baton to Successor Post author:Sam Post published:January 23, 2018 Post category:BioPharma Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace You Might Also Like Gilead HCV Woes Continue and Investors are Spooked October 26, 2017 Achaogen Announces Leadership Promotions February 23, 2017 <b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017
<b>Vividion Therapeutics</b> Launches With $50 Million and a Celgene Alum as Executive Chairman February 1, 2017